Institutional investors control 16.57% of the outstanding shares in BGMD. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended June 2015, these large investors purchased a net $984.8 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMPERY ASSET MANAGEMENT LP Bought 1.1 Million shares of BG Medicine Inc
THE VANGUARD GROUP, INC. Bought 711.00 shares of BG Medicine Inc
GEODE CAPITAL MANAGEMENT LLC Sold 2.00 shares of BG Medicine Inc